Publicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Bioingeniería, Biomateriales y Nanomedicina (14)

2023

  1. Ag2S Biocompatible Ensembles as Dual OCT Contrast Agents and NIR Ocular Imaging Probes

    Small, Vol. 19, Núm. 49

  2. Amphiphilic Dendritic Hydrogels with Carbosilane Nanodomains: Preparation and Characterization as Drug Delivery Systems

    Chemistry of Materials, Vol. 35, Núm. 7, pp. 2797-2807

  3. Remote control of transgene expression using noninvasive near-infrared irradiation

    Journal of Photochemistry and Photobiology B: Biology, Vol. 242

2022

  1. Alteration of the HIF-1α/VEGF Signaling Pathway and Disruption of the Cell Cycle by Second Generation Carbosilan Dendrimers

    Biomacromolecules, Vol. 23, Núm. 12, pp. 5043-5055

2021

  1. Adrenergic Modulation With Photochromic Ligands

    Angewandte Chemie - International Edition, Vol. 60, Núm. 7, pp. 3625-3631

2020

  1. Cyclopentadienyl ruthenium(II) carbosilane metallodendrimers as a promising treatment against advanced prostate cancer

    European Journal of Medicinal Chemistry, Vol. 199

  2. Dendritic nanotheranostic for the delivery of infliximab: A potential carrier in rheumatoid arthritis therapy

    International Journal of Molecular Sciences, Vol. 21, Núm. 23, pp. 1-17

  3. Heterofunctional ruthenium(II) carbosilane dendrons, a new class of dendritic molecules to fight against prostate cancer

    European Journal of Medicinal Chemistry, Vol. 207

2019

  1. A chronic ocular-hypertensive rat model induced by injection of the sclerosant agent polidocanol in the aqueous humor outflow pathway

    International Journal of Molecular Sciences, Vol. 20, Núm. 13

  2. Anticancer Activity of Dendriplexes against Advanced Prostate Cancer from Protumoral Peptides and Cationic Carbosilane Dendrimers

    Biomacromolecules, Vol. 20, Núm. 3, pp. 1224-1234

  3. In vitro and in vivo evaluation of first-generation carbosilane arene Ru(II)-metallodendrimers in advanced prostate cancer

    European Polymer Journal, Vol. 113, pp. 229-235

  4. Insight into the antitumor activity of carbosilane Cu(ii)-metallodendrimers through their interaction with biological membrane models

    Nanoscale, Vol. 11, Núm. 28, pp. 13330-13342

2017

  1. The S1P1 receptor-selective agonist CYM-5442 protects retinal ganglion cells in endothelin-1 induced retinal ganglion cell loss

    Experimental Eye Research, Vol. 164, pp. 37-45

2016

  1. Polyphenolic carbosilane dendrimers as anticancer agents against prostate cancer

    New Journal of Chemistry, Vol. 40, Núm. 12, pp. 10488-10497